4880.T
CellSource Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 341.00
−0.58%Year over year
Reported trailing growth
- Revenue
- -7.7%
- EBITDA
- —
- EBIT
- +308.0%
- EPS
- +79.3%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -8.2%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -4.6%
- EBITDA
- -39.1%
- EBIT
- -52.7%
- Net income
- -78.6%
- EPS
- -78.5%
- Free cash flow
- -27.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jan 1, 2026